The European Asthma Research and Innovation Partnership (EARIP) aims to reduce asthma deaths in Europe by 25% within ten years and by 50% within 20 years. The partnership, made up of 12 European-based organisations, also aims to halve hospital admission rates, speed up the discovery of new treatments and improve self-management. The EARIP project will do this through identifying key gaps in asthma knowledge; it will then address these using a pioneering and integrated approach to research, development and innovation across Europe. Through rapid dissemination of project results, EARIP will ensure that outcomes from knowledge-based asthma research will quickly result in an improved quality of life for people with asthma.
Recent Posts
- Quick Take: Depemokimab in Severe Asthma
- Analysis of the correlations and inconsistencies between spirometry and impulse oscillometry in the diagnosis of small-airway dysfunction
- Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care
- Cost-related non-adherence to medications among adults with asthma in the USA, 2011–2022
- Allergen Immunotherapy: Optimal Duration for Respiratory Allergy